XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives
9 Months Ended
Sep. 30, 2021
Derivatives [Abstract]  
Derivatives

Note 9. Derivatives

The Company utilizes derivative instruments to assist in the management of interest rate sensitivity by modifying the repricing, maturity and option characteristics on certain non-SBA CRE loans held at fair value. These instruments are not accounted for as effective hedges. As of September 30, 2021, the Company had entered into three interest rate swap agreements with an aggregate notional amount of $21.3 million. These swap agreements provide for the Company to receive an adjustable rate of interest based upon the three-month LIBOR. The Company recorded a net gain of $1.3 million for the nine months ended September 30, 2021 to recognize the fair value of the derivative instruments which is reported in net realized and unrealized gains (losses) on commercial loans, at fair value, in the consolidated statements of operations. The amount payable by the Company under these swap agreements was $895,000 at September 30, 2021, which is reported in other liabilities. The Company had minimum collateral posting thresholds with certain of its derivative counterparties and had posted cash collateral of $2.3 million as of September 30, 2021.

The maturity dates, notional amounts, interest rates paid and received and fair value of the Company’s remaining interest rate swap agreements as of September 30, 2021 are summarized below (dollars in thousands):

September 30, 2021

Maturity date

Notional amount

Interest rate paid

Interest rate received

Fair value

December 23, 2025

6,800 

2.16%

0.13%

(348)

December 24, 2025

8,200 

2.17%

0.13%

(426)

July 20, 2026

6,300 

1.44%

0.13%

(121)

Total

$

21,300 

$

(895)